Every year, we hold a workshop for regulatory affairs analysts.

​

This free activity welcomes 25 participants and aims to be a great exchange of experiences on the topics, documents and regulatory practices with the greatest impact on the approval of drug registration and post-registration dossiers by ANVISA.